Ocugen Inc. (United States) is listed on the Nasdaq and has a market capitalization of $276.97 million, with shareholders equity totaling $-17.68 million.
The company employs approximately 56 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Ocugen Inc. reported $4.78 million in revenue, generating net income of $-65.36 million.
Key financial metrics include a P/E ratio of -4.24, a price-to-book (P/B) ratio of -15.66, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker OCGN.